ICompany · Foodtech & Agtech
InProteins
InProteins (legal name In Proteins For All, S.L.) is a Spanish foodtech company developing plant-based protein ingredients — concentrates, isolates, hydrolysates and custom powders — using a proprietary hybrid green-chemistry/biotech extraction process. It is building Spain's first integrated plant-based protein production plant in Curtis, A Coruña (Galicia), backed by a joint investment from beer group Hijos de Rivera and the Xunta de Galicia's public venture arm Xesgalicia (total project cost reported near €18M), with the plant expected to start operations in late 2026; it also runs an R&D facility (Imagine Labs) in Camas, Seville.
Founded
2022
Founders
2
News
0
Rounds
0
Investors
1
SectorsFoodTech, Alternative Proteins, Biotechnology, Sustainable Food Production
Start-up MapFoodtech & Agtech › Alternative protein & novel ingredients
Profile updated 1 Aug 2026
Founders
A
Ana Rosa Caamaño Vara
CEO & Co-founder
H
Héctor Ara Sanz
Co-founder
Global models 5
P
Perfect Day
United States · perfectday.com ↗
Uses biotech fermentation to produce animal-free protein ingredients sold B2B to food manufacturers, the same ingredient-supplier model as InProteins.
$750MComparable
ŸŸnsect
France · ynsect.com ↗
Built large-scale industrial facilities to manufacture alternative protein ingredients from insects for food/feed customers, mirroring InProteins' industrial ingredient-plant approach.
$600MComparable
NNature's Fynd
United States · naturesfynd.com ↗
Fermentation-based protein ingredient producer supplying food manufacturers, comparable biotech-to-ingredient production model.
$500MComparable
M
Motif FoodWorks
United States · motif.inc ↗
Develops and manufactures functional plant-based protein ingredients for food companies, closely matching InProteins' B2B ingredient focus.
$345MComparable
EENOUGH
United Kingdom · www.enough-food.com ↗
Operates industrial-scale mycoprotein production plants supplying alternative-protein ingredients, the closest match to InProteins' plant-manufacturing model.
$111MComparable
Investors 1
Funding rounds
No announced rounds on record.
News & media
No coverage on record yet.
